| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Workplace Communication > Netiquette - Strategies to Acquire Creditability and Reputation as an Onliner - Concluding Part |
|
Useful Advices - Netiquette - Strategies to Acquire Creditability and Reputation as an Onliner - Concluding Part
For those of us who are new online, let us raise our right hands and swear: We will not forward any dumb joke, chain letter or unimportant e-mails to my friends without their permission. We reali According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ze that by doing so we may fill up their inbox, use others’ resources unnecessarily, and may cause other, important e-mail to bounce. We realize that most people have already gone through these e- ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in mails a thousand times and find them annoying. We know that by forwarding these so called humorous e-mails we may tick off people who do not share my sense of humor or who are sick of having silly lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e-mails forwarded to them each time a newbie hops online. So now that we have taken an oath so solemnly, we will no longer be tempted to forward those jokes, untruthful or frivolous e-mail that i here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe nstruct you to forward them to your friends! We do not want to look silly and uninformed before the whole world! Do we? Let us read them if curiosity vanquishes reason but then let us hit ‘Delete’. d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro Nothing can
really happen to us simply by our forwarding the e-mail to 10 friends, can it? Beware of hoax e-mails too! These may appear good-intentioned with an incredible story that instructs ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc you to “read and share” with everyone you know but it’s a good idea to first check to see if the story is legitimate in the first place. Not doing so can have you eating crow when everyone you e-ma easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi il is informed, you just forwarded a hoax without knowing better. It’s no use getting mad at someone afterwards if they hold you responsible for perpetuating the hoax. If you don’t know for a fact nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically that the e-mail you are forwarding is accurate specifically apropos to the person you are forwarding to and you know they will want to receive it—all you have to do is ask first. Don’t give out ph and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ one numbers or personal information before you convince yourself that you are communicating with a reputable party. And it doesn’t need saying that you should not give out personal contact informat ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ion of others without their specific permission to do so. Don’t just shoot off an e-mail to a webmaster with your query before going through the FAQ or About Us section of the Web site. You could ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a be wasting the site owner’s time. No one person’s time is more important than another’s, and common courtesy includes respecting this fact. If you do not find what you are looking for, search for dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod the appropriate contact area for your question. Don’t just click on the first e-mail link you come across and blurt out your question. Your query goes unanswered if the information is easily found cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin on the site. We must understand the focus of each Web site as well. Each site can not serve the purpose of too many, or be what you perceive it should be. Take your time to review the information tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen provided to double-check that what you seek would even be covered by the site you are visiting. Do not ask for Return Receipt Request (RR) for each and every personal e-mail you send because you w t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ant to confirm if your e-mail has been opened or not. This is simply annoying to the recipient. How would you like it if every time you heard a voice mail, answering machine message, or opened a po ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust stal letter from a friend, it was immediately reported back to them that you had heard/opened their communications? The recipient should have the privacy to determine when/if they want to open, rea y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products d and reply—period. RRs should be reserved for those instances where it is critical to knowing whether the e-mail was opened. Some legal and important business issues may justify this but keep in m . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ind that opened doesn’t mean read, and the recipient can decline an RR request so you will not be notified. Last but not the least, don’t fall for flamers, jerks or trolls. Trolling is the practic elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e of sending or posting obviously offensive comments, insulting and untruthful statements or words and phrases that all we know to be those that would instigate a fight if stated at your local pub. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Brochures - The Ultimate Sales Tool What is Company Fraud and How Do You Stop It? (Part 1 of 2) All You Need to Know About Press Release Writing and Distribution
|